% Expired Patents = 100.0

Trademarks = 1

Forward Citations = 127

Loading Chart...

10 inventors (with patents filed for the assignee):

Richard J Whitbourne (4 out of 15 patents)

Daniel G Hullihen (3 out of 3 patents)

Michael R Violante (2 out of 11 patents)

4. Alexandra M Chamberlain (2 out of 2 patents)

5. Scott F Rosebrough (2 out of 6 patents)

6. Mildred Calistri-Yeh (2 out of 10 patents)

7. Frank Guo-Bin Wang (1 out of 1 patent)

8. Xianping Zhang (1 out of 5 patents)

9. John F Lanzafame (1 out of 3 patents)

10. Margaret Lydon (1 out of 3 patents)

4 patents: Sort by Forward Citations

1. 8287590 - Medicated stent having multi-layer polymer coating (2012-10-16),

2. 8101200 - Targeted therapeutic agent release devices and methods of making and using the same (2012-01-24),

3. 7771468 - Medicated stent having multi-layer polymer coating (2010-08-10),

4. 7229413 - Echogenic coatings with overcoat (2007-06-12),

Company Overview

Angiotech Biocoatings, Inc. is a leading provider of innovative biomaterial coatings for medical devices. Their coatings are designed to improve device functionality and patient outcomes. With a focus on precision and quality, Angiotech Biocoatings delivers cutting-edge solutions for the healthcare industry.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

4 Patents

#6 in

#60,641 in

Henrietta, NY, United States of America

Angiotech Biocoatings, Inc.

Forward Citations = 127

10 inventors:

Richard J Whitbourne (4 out of 15 patents)

Daniel G Hullihen (3 out of 3 patents)

Michael R Violante (2 out of 11 patents)

4. Alexandra M Chamberlain (2 out of 2 patents)

5. Scott F Rosebrough (2 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Angiotech Biocoatings, Inc.. Retrieved from https://idiyas.com/company/angiotech-biocoatings

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]